Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease-Reference-Cited by-同舟云学术

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease

Published:2004-02 Issue:2 Volume:126 Page:402-413
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Rutgeerts Paul,Feagan Brian G.,Lichtenstein Gary R.,Mayer Lloyd F.,Schreiber Stefan,Colombel Jean Frederic,Rachmilewitz Daniel,Wolf Douglas C.,Olson Allan,Bao Weihang,Hanauer Stephen B.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference19 articles.

1. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection;Kindler;Cell,1989

2. Tumour necrosis factor α in stool as a marker of intestinal inflammation;Braegger;Lancet,1992

3. Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease;Breese;Gastroenterology,1994

4. Tumor necrosis factor-α and interferon-γ production measured at the single cell level in normal and inflamed human intestine;MacDonald;Clin Exp Immunol,1990

5. Tumour necrosis factor α and interleukin 1β in relapse of Crohn’s disease;Schreiber;Lancet,1999

Cited by 813 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of the secreted Kazal-type serine protease inhibitor SPINK4 in colitis;Nature Communications;2024-07-12

2. Education level and biologic therapy are the related factors of mucosal healing in Patients with Crohn’s disease;Arab Journal of Gastroenterology;2024-07

3. Stem Cells and Stem Cell-Derived Factors for the Treatment of Inflammatory Bowel Disease with a Particular Focus on Perianal Fistulizing Disease: A Minireview on Future Perspectives;BioDrugs;2024-06-25

4. Network meta‐analysis: Comparative onset of early effect of biologics and small molecules in moderately to severely active luminal Crohn's disease;Alimentary Pharmacology & Therapeutics;2024-06-11

5. The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus;Autoimmunity Reviews;2024-05